RxDoctor Payments Data

Vinayak Rohan, MD

Transplant Surgery · Chicago, ILNPI 1033497094

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $62,393 of the $94,977 with a category attached, or 65.7%. Merck accounts for 80.9% of it on its own, with 10 other manufacturers making up the rest. Among transplant surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$94,977in general payments, 2019–2025

Across 101 payments — averaging $940.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$77K
  • Intuitive Surgical$9K
  • Veloxis Pharmaceuticals, Inc.$6K
  • Mesh Suture Inc$2K
  • Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$206
  • Mallinckrodt Hospital Products Inc.$171
  • plus $280 from 5 others
$572,932in research payments, 2019–2025

Across 245 payments — averaging $2338.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$362K
  • Phraxis, Inc.$164K
  • Takeda Pharmaceuticals U.S.A., Inc.$44K
  • Shire North American Group Inc$2K

What the payments were for

  • Consulting fees$8,1259%
  • Speaking & faculty fees$62,39366%
  • Travel & lodging$16,58217%
  • Food & beverage$1,7862%
  • Education$6,0926%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$94,977 in reported general payments places this provider in the 95th percentile of 52 transplant surgery providers in Illinois.

See all transplant surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$137,372
Medicare patients
82
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →